荃银高科(300087) - 2022 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2022 reached ¥570,565,404.15, representing a 9.41% increase compared to the previous quarter and a 28.09% increase year-to-date[6]. - The net profit attributable to shareholders was ¥7,347,291.27, showing a decrease of 13.64% from the previous quarter, but a significant increase of 4,043.42% year-to-date[6]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥29,920,273.91, reflecting a decrease of 782.82% from the previous quarter and an 86.85% decline year-to-date[6]. - Revenue for the first nine months of 2022 reached ¥1,535,963,577.87, an increase of 28.09% compared to ¥1,199,165,871.05 in the same period of 2021[12]. - The company achieved operating revenue of RMB 153,596.36 million in 2022, representing a year-on-year growth of 28.09%[21]. - Net profit attributable to shareholders reached RMB 3,782.58 million, an increase of RMB 3,878.50 million compared to the same period last year[21]. Assets and Liabilities - The total assets as of the end of Q3 2022 amounted to ¥4,901,997,693.83, which is a 38.54% increase compared to the end of the previous year[6]. - Total liabilities reached ¥3,126,589,533.33, up from ¥1,887,436,723.89, indicating a rise of 65.73%[30]. - Total equity attributable to shareholders of the parent company was ¥1,381,539,371.28, slightly up from ¥1,373,411,767.86[30]. - The company reported a long-term investment in equity of ¥11,102,457.76, compared to ¥1,962,544.07 in the previous period, showing a substantial increase[30]. Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥546,613,435.06, marking a 13.19% increase[6]. - Net cash inflow from operating activities was ¥546,613,435.06, reflecting a 13.19% increase from ¥482,912,394.58 year-on-year[12]. - Cash flow from investment activities saw a significant increase of 317.23%, totaling ¥1,646,194,165.42, mainly due to the redemption of financial products during the reporting period[12]. - The company reported a cash outflow from investment activities totaling ¥1,602,793,327.23, compared to ¥1,135,255,168.58 in the previous period, reflecting an increase of about 41%[41]. Expenses - Operating costs increased by 29.86% to ¥1,229,411,215.9 from ¥946,755,960.96 year-on-year, primarily due to increased sales in the seed industry[12]. - Financial expenses decreased by 76.70% to ¥4,362,624.48, attributed to increased foreign exchange gains and interest income compared to the previous year[12]. - Sales expenses increased to 134,561,051.62 from 105,490,539.52, reflecting a growth of approximately 27.6%[34]. - Research and development expenses rose to 41,380,656.37, up from 38,530,023.83, indicating an increase of about 4.8%[34]. Investments and Acquisitions - The company intends to acquire a 60% stake in Xinjiang Jinfengyuan Seed Industry Co., Ltd. for RMB 20,673.762 million, with a proposed merger loan of up to RMB 12,000 million[23]. - The company approved a financial derivatives business to mitigate risks related to exchange rates and commodity price fluctuations, with a maximum limit of RMB 65,000 million[23]. - Investment income surged by 186.38% to ¥10,344,288.46, driven by higher returns from financial products compared to the same period last year[12]. Shareholder Information - The basic earnings per share for Q3 2022 was ¥0.0110, down 45.54% from the previous quarter, but up 2,565.22% year-to-date[6]. - The total number of restricted shares at the end of the period was 37,490,240, with no shares released from restriction during the period[20]. - The company reduced the amortization expense of the first employee stock ownership plan by RMB 2,531.37 million compared to the previous year[21]. Future Plans - The company plans to use up to RMB 45,000 million of idle raised funds for cash management, with a maximum investment period of 6 months[23]. - The company plans to continue expanding its market presence and investing in new product development[28].